Arkolith/Insider Trading/CNTX/Form 4

Lehr Martin A.

Chief Executive Officer, DirectorContext Therapeutics Inc. (CNTX) · full profile →Form 4 · filed Jan 30, 2023
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2023Buy(P)7K$0.70$5K143K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001842952-23-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML